glp 1 drug history GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art The Landscape Of GLP-1 Receptor
Description
This is where most concentration confusion begins
10.1016/j.tem.2024.10.005 Trends Endocrinol Metab
The overall hazard ratio (HR) estimate was 0.59 (95% CI 0.400.79), indicating that tirzepatide resulted from a significant reduction in the risk of MACE-4 compared to the control group [21]
Truncated forms of BNP with lower enzymatic activity are discussed as an indicator of heart failure severity
